Past grant recipients
- Boosting dementia research leadership fellowships
- Career development fellowships
- Centres of research excellence
- Dementia research development fellowships
- Development grants
- Early career fellowships (previously Training Fellowships)
- Ideas grants
- Investigator grants
- Project grants
- Research fellowships
- Senior research fellowship
- Translating research into practice fellowship (TRIP)
| Year | Name | Title | Agency ref. no. | Total |
|---|---|---|---|---|
| 2017 | Thomas Astell-Burt | Do urban green spaces help to reduce incidence of Alzheimer's and associated risk factors? Multilevel longitudinal study of 267,153 adults with 15 years of follow-up | APP1140317 | $719,840.80 |
| 2017 | Lezanne Ooi | Neuronal membranes and connections in dementia: targets for intervention | APP1135720 | $720,144.00 |
| Year | Name | Title | Agency ref. no. | Total |
|---|---|---|---|---|
| 2018 | Xiaoqi Feng | Classifying local environment attributes for healthier, more equitable child development | APP1148792 | $431,000 |
| 2015 | Justin Yerbury | Protein homeostasis, protein aggregation and amyotrophic laterial sclerosis | APP1084144 | $411,768 |
| 2011 | Martina Sanderson-Smith | Defining the role of plasminogen activation in group A streptococcal invasive | APP1009369 | $384,160 |
| Year | Name | Title | Agency ref. no. | Total |
|---|---|---|---|---|
| 2017 | Rodney Croft | The Australian Centre for Electromagnetic Bioeffects Research | APP1135076 | $2,499,671 |
| 2012 | Rodney Croft | The Australian Centre for Electromagnetic Bioeffects Research | APP1042464 | $2,498,842 |
| Year | Name | Title | Agency ref. no. | Total |
|---|---|---|---|---|
| 2016 | Lyn Phillipson | Consumer Directed Care: Understanding and promoting participation and care outcomes for people living with dementia in receipt of a Home Care Package | APP1107401 | $571,648 |
| Year | Name | Title | Total |
|---|---|---|---|
| 2016 | Dr Marco Petasecca, Prof Anatoly Rozenfeld, A/Prof Michael Lerch, Dr Joseph Bucci, Mr Marco Favoino, Mr Francesco Carriero | 3D-BrachyView: a 3D real-time virtual reality intra-operative Quality Assurance system for brachytherapy | $359,105 |
| 2015 | Michael Lerch | X-RATE: A novel radiation detector platform to realise new opportunities in radiotherapy at the Australian Synchrotron | $337,077 |
| 2011 | Michael Lerch | Radiosurgery with sub-millimeter x-ray beams: development of the X-Tream realtime beam monitoring and Quality Assurance system | $394,615 |
| 2010 | Mark Walker | Preclinical studies of group A streptococcal vaccine candidates | $483,600 |
| 2010 | Anatoly Rozenfeld | BrachyVision: A novel multipurpose probe for in-body radiation imaging and dosimetry. | $523,500 |
| Year | Name | Title | Total |
|---|---|---|---|
| 2017 | Jiamei Lian | Early antipsychotic exposure during childhood and adolescence: Does it lead to long term brain and behaviour changes in adulthood? | $318,768 |
| 2013 | Deborah Apthorp | Effects of electromagnetic radiation on visual processing | $299,564 |
| 2011 | Karen Mickle | Understanding toe muscle weakness to restore foot function in older individuals with toe deformities | $280,032 |
| 2011 | Amy Wyatt | The role of clusterin in preventing atherosclerosis | $280,032 |
| 2010 | Mei Han | Understanding the role of neuregulin1 genetic polymorphisms in patients with schizophrenia | $318,600 |
| 2010 | Mark Davies | Defining the emergence, initiation and evolution of invasive Streptococcal infections | $309,668 |
| 2009 | Yasmine Probst | Supporting research underpinning evidence based practice: dietary assessment in clinical trials | $199,500 |
| 2009 | Debbie Watson | Targeting the human immune response to bacterial superantigens | $142,500 |
| 2009 | Yinghua Yu | Evaluation of functional protein molecules in treating obesity | $341,768 |
|
Year |
Name |
Title |
Total |
|
2022 |
Chris Degeling |
Preparing Australia for the next pandemic: Managing controversy; promoting trust |
$840,776.50 |
|
2022 |
Anatoly Rozenfeld |
Enabling next generation radiotherapy for cancer: Development of novel Quality Assurance instrumentation for Proton Therapy |
$758,040 |
|
2021 |
Jeremy Crook |
A wireless electric nerve-guide for peripheral nerve repair |
$805,065 |
|
2021 |
Steven Howard |
Development and evaluation of a novel early language assessment tool to identify vulnerable children who would benefit from referral to Allied Health pathways |
$554,388 |
|
2020 |
Gokhan Tolun |
Revealing the molecular mechanistic details of viral DNA recombination towards developing novel anti-viral drugs |
$636,368 |
|
2020 |
Stacy Carter |
The algorithm will see you now: ethical, legal and social implications of adopting machine learning systems for diagnosis and screening |
$823,477 |
|
2020 |
Marie Ranson |
Cutaneous Squamous Cell Carcinoma: defining prognostic markers of metastasis |
$597,624 |
|
2020 |
Chao Deng |
Exposures of mobile phone radiofrequency electromagnetic energy in juveniles: effects on brain development and behaviours |
$1,264,200 |
| Year | Name | Award | Title | Total |
|---|---|---|---|---|
| 2022 | Lisanne Spenkelink |
Investigator Grant Emerging Leadership Level 1 |
Rapid evolution of a genome editing tool | $650,740 |
| 2021 | Caleb Ferguson | Investigator Grant Emerging Leadership Level 1 | INFORM-AF a randomised controlled trial to assess the efficacy of a digital education program for atrial fibrillation | $613,233 |
| 2021 | Antoine van Oijen | Investigator Grant Leadership Level 2 | Roadblocks to DNA replication and implications for antimicrobial resistance | $1,050,000 |
| 2021 | Justin Yerbury | Investigator Grant Leadership Level 2 | Using Proteostasis framework to understand and develop therapies for MND | $2,238,220 |
| 2020 | Yee Lian Chew | Investigator Grant Emerging Leadership Level 1 | Investigating Neuroendocrine Dysregulation as New Targets for Chronic Pain Management | $639,750 |
| 2020 | Monique Francois | Investigator Grant Emerging Leadership Level 1 | Optimising Lifestyle Treatment and Prevention of Diabetes | $639,750 |
| 2020 | Xu-Feng Huang | Investigator Grant Leadership Level 2 | Neurite deficits, obesity and cortical thinning: Prevention and treatment in schizophrenia | $1,500,000 |
| 2020 | Tony Okely | Investigator Grant Leadership Level 2 | Understanding and promoting physical activity and reducing sedentary behaviour in young children | $2,000,000 |
| Year | Name | Title | Total |
|---|---|---|---|
| 2018 | Martina Sanderson-Smith | Blood group antigen recognition by Group A Streptococcus mediates host colonisation | $470,821 |
| 2017 | Nadia Solowij | Characterising neurobiological abnormalities in Cannabis Use Disorders | $731,571.20 |
| 2017 | Stephen Pyne, Paul Keller | From lead compounds to potential therapeutics: Drugs to treat Clostridium Difficile Infections. | $523,460.00 |
| 2017 | Anatoly Rozenfeld, Michael Lerch, Marco Petasecca | Fast and efficient assessment of dose in small targets in radiotherapy: Effect of motion in clinical research and implementation of dynamic therapy. | $501,264.50 |
| 2016 | Michael Kelso, Marie Ranson, Mingdong Huang | Repurposing Amiloride into Breast Cancer Drugs with a Dual-Targeting Mechanism | $611,966 |
| 2016 | Chao Deng, Jiamei Lian | Understanding the mechanisms for ameliorating/preventing antipsychoticinduced obesity in paediatric patients | $576,495.50 |
| 2016 | Amy Wyatt (New Investigator) | The effect of hypochlorite on the toxicity and clearance of the Alzheimer's disease-associated amyloid beta peptide | $461,495.50 |
| 2015 | Moeava Tehei | Design and application of new nanomaterials theranostic platforms for targeted treatment of cancer | $514,154 |
| 2015 | Brett Garner | Isoform-dependent apoE processing by human induced pluripotent stem cells. A novel pathway linking APOE genotype and Alzheimer’s disease risk. | $416,660 |
| 2014 | Anthony Okely | Increasing physical activity among young children from disadvantaged communities: A group randomised controlled effectiveness trial | $1,064,324 |
| 2014 | Robert Kapsa | Biopolymer Conduit for Peripheral Nerve Repair. | $605,558 |
| 2014 | Xu-Feng Huang | Application of intelligent conducting polymers for treating schizophrenia and allied disorders focusing on neuronal outgrowth, myelination and synaptogenesis | $675,558 |
| 2014 | Lezanne Ooi | Supporting a friend: the role of the molecular scaffold CoREST family in chromatin regulation and neuroprotection | $343,447 |
| 2014 | Brett Garner | A novel roadblock to vitamin B12 transport in the brain | $536,124 |
| 2013 | Stephen Pyne | The development of novel antibacterials targeting clostridium difficile infections | $723,714 |
| 2013 | Chao Deng | Roles of muscarinic M3 receptors in antipsychoticinduced metabolic side-effects: prevention and treatment of anti-psychotic insulin dysregulation | $583,611 |
| 2012 | Nicholas Dixon | Targeting Nucleic Acid Synthesis and Cell Division in Gram-Negative Bacterial Pathogens | $934,319 |
| 2012 | Xu-Feng Huang | Schizophrenia: reversal of antipsychotic drug-induced obesity and its related metabolic disorders | $597,987 |
| 2012 | Anatoly Rozenfeld | Improving radiation therapy of static and moving targets using high spatial resolution realtime dosimeters | $526,325 |
| 2011 | Nicholas Dixon | Targeting lagging strand DNA replication in model and pathogenic bacteria | $570,048 |
| 2011 | Chao Deng | Understanding the mechanisms of functionally selective drugs: implication for new generation antipsychotic drugs | $359,182 |
| 2011 | Brett Garner | Defining the function of apolipoproteinD in Alzheimers disease | $440,312 |
| 2011 | Nadia Solowij | Vulberability markers in the association between cannabis and schizophrenia | $499,006.40 |
| 2011 | Justin Yerbury | Investigating the propagation of protein aggregation in amyotrophic lateral sclerosis | $390,812.40 |
| Year | Name | Title | Total |
|---|---|---|---|
| 2010 | Brett Garner | Research Fellowships | $234,329 |
| Year | Name | Title | Total |
|---|---|---|---|
| 2016 | Brett Garner | Defining the mechanisms by which ABCA7 and apoE control Alzheimer's disease risk. Functional characterisation of new therapeutic targets for dementia prevention and treatment. | $687,975 |
| Year | Name | Title | Total |
|---|---|---|---|
| 2018 | Kelly Lambert | Implementing a health literacy focused dietetic outpatient model of care for people with chronic kidney disease | $179,118 |
| 2014 | Yasmine Probst | From nutrients to foods to cuisines: Growing food composition data knowledge for more robust evidence-based advice | $170,689 |